Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1/2 3Phase 1 2Phase 3 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms by Histologic Type 2Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myeloid 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Hematologic Diseases 2Bone Marrow Diseases 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Leukemia, Myeloid, Chronic-Phase 1Immunoproliferative Disorders 1Immune System Diseases 1

Interventions

Methotrexate 48Cyclophosphamide 47Vincristine 39Cytarabine 36Dexamethasone 33Mercaptopurine 32pegaspargase 30Doxorubicin 29Daunorubicin 26Etoposide 24Asparaginase 23Prednisone 22Radiotherapy 18Thioguanine 15Leucovorin 14Calcium Dobesilate 14merphos 12Prednisolone 12blinatumomab 11Hydrocortisone 10Whole-Body Irradiation 9dexamethasone acetate 8azathiopurine 8Methylprednisolone 8Ifosfamide 8Filgrastim 8Cyclosporine 8fludarabine 7dexamethasone 21-phosphate 7auricularum 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × ponatinib × Clear all
NCT04722848 2025-01-23

Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 3 Active not recruiting
236 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡